Journal article

Decline in angiogenic factors, such as interleukin-8, indicates response to chemotherapy of metastatic melanoma

S Brennecke, M Deichmann, H Naeher, H Kurzen

Melanoma Research | LIPPINCOTT WILLIAMS & WILKINS | Published : 2005

Abstract

Serum concentrations of angiogenic factors have been reported to correlate with tumour burden and prognosis in metastatic melanoma. The present study was performed to assess the value of angiogenic factors in serum in indicating response or failure to chemotherapy and immunochemotherapy in stage IV melanoma. Thirty-five patients suffering from stage IV melanoma according to the American Joint Committee on Cancer (AJCC) criteria were included in this prospective study. Before and following chemotherapy or immunochemotherapy, serum levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF-AB), vascular cell adhesion molecul..

View full abstract